Skip to main content

Table 2 Demographic and clinical variables before and after propensity score matching

From: Synthetic colloids as priming fluids in cardiopulmonary bypass and postoperative acute kidney injury: a propensity score-matched study

Variables

Before PSM

After PSM

The gelatin group (n = 1921)

The HES group (n = 12,522)

P

The gelatin group (n = 1880)

The HES group (n = 1880)

P

Female, n (%)

523 (27.2)

3497 (27.9)

0.523

506 (26.9)

484 (25.7)

0.985

Age, years, mean ± SD

57.3 ± 10.8

57.3 ± 10.8

0.839

57.3 ± 10.7

57.4 ± 10.6

0.753

BMI, kg/m2, mean ± SD

25.25 ± 3.27

25.08 ± 3.25

0.094

25.27 ± 3.29

25.27 ± 3.22

0.854

BSA, m2, mean ± SD

1.90 ± 0.18

1.89 ± 0.18

0.271

1.90 ± 0.41

1.90 ± 0.19

0.975

EF, %

62 ± 7

61 ± 7

0.002

61 ± 7

61 ± 7

0.375

EuroSCORE

  

 < 0.001

  

0.795

Low risk (0–2)

1366 (71.1)

7810 (62.4)

 

1336 (71.1)

1348 (71.7)

 

Medium risk (3–5)

486 (25.3)

4135 (33.0)

 

476 (25.3)

471 (25.1)

 

High risk (≥ 6)

69 (3.6)

577 (4.6)

 

68 (3.6)

61 (3.2)

 

Comorbidities, n (%)

 Smoking

792 (41.2)

5342 (42.7)

0.237

779 (41.4)

819 (43.6)

0.187

 Diabetes mellitus

399 (20.8)

2568 (20.5)

0.791

390 (20.7)

395 (21.0)

0.841

 Hypertension

854 (44.5)

5760 (46.0)

0.206

836 (44.5)

888 (47.2)

0.089

 Hyperlipidemia

733 (38.2)

4775 (38.1)

0.984

714 (38.0)

744 (39.6)

0.315

 Cerebrovascular accidents

76 (4.0)

588 (4.7)

0.150

75 (4.0)

67 (3.6)

0.494

 History of cardiac surgery

58 (3.0)

319 (2.5)

0.277

58 (3.1)

63 (3.4)

0.644

Laboratory tests prior to cardiac surgery

 Hemoglobin, g/L

136 (128, 146)

136 (127, 145)

0.443

136 (128, 146)

136 (129, 145)

0.837

 HCT, %

0.430 (0.400, 0.492)

0.430 (0.395, 0.509)

0.999

0.430 (0.400, 0.491)

0.430 (0.396, 0.497)

0.759

 Platelet counts, *109/L

197 (173, 230)

197 (168, 227)

0.027

197 (173, 227)

197 (171, 226)

0.288

 Albumin, g/L

40.4 (38.3, 42.2)

40.4 (38.6, 42.5)

0.082

40.4 (38.3, 42.3)

40.4 (38.3, 42.5)

0.816

 ALT, IU/L

19 (14, 27)

19 (14, 27)

0.553

19 (14, 27)

19 (14, 26)

0.150

 AST, IU/L

22 (18, 26)

22 (18, 26)

0.702

22 (18, 26)

22 (18, 26)

0.913

 Creatinine, μmol/L

84.90 (74.39, 95.86)

84.00 (74.13, 95.94)

0.475

84.92 (74.40, 95.74)

84.29 (74.76, 95.65)

0.563

 Blood urea nitrogen, mmol/L

6.18 (5.13, 7.55)

6.09 (5.01, 7.60)

0.139

6.18 (5.13, 7.55)

6.13 (5.11, 7.58)

0.456

Preoperative medication

 Diuretics

282 (14.7)

1996 (15.9)

0.158

275 (14.6)

283 (15.1)

0.714

 Vasoactive agents

179 (9.3)

1203 (9.6)

0.688

174 (9.3)

183 (9.7)

0.617

 β-receptor blocker

1091 (56.8)

7292 (58.2)

0.234

1067 (56.8)

1117 (59.4)

0.098

 ACEI/ARB

296 (15.6)

1968 (15.7)

0.730

289 (15.4)

294 (15.6)

0.822

 CCB

80 (4.2)

628 (5.0)

0.108

79 (4.2)

96 (5.1)

0.188

Years of performing surgery

 

 < 0.001

  

0.997

 2018

239 (12.4)

3407 (27.2)

 

236 (12.6)

242 (12.9)

 

 2019

383 (19.9)

3087 (24.7)

 

375 (19.9)

370 (19.7)

 

 2020

327 (17.0)

1884 (15.0)

 

325 (17.3)

321 (17.1)

 

 2021

634 (33.0)

2876 (23.0)

 

614 (32.7)

618 (32.9)

 

 2022

338 (17.6)

1268 (10.1)

 

330 (17.6)

329 (17.5)

 

 Types of surgery

  

0.552

  

0.270

 CABG

748 (38.9)

4875 (38.9)

 

730 (38.8)

762 (40.5)

 

 Valve

779 (40.6)

5139 (41.0)

 

762 (40.5)

706 (37.6)

 

 CABG combined with valve

139 (7.2)

973 (7.8)

 

136 (7.2)

153 (8.1)

 

 Major aortic surgery

255 (13.3)

1535 (12.3)

 

252 (13.4)

259 (13.8)

 

Perfusion characteristics

 CPB time, min

114 (92, 144)

109 (87, 139)

 < 0.001

114 (92, 144)

113 (92, 145)

0.784

 ACC time, min

83 (65, 108)

79 (61, 104)

 < 0.001

83 (65, 108)

83 (65, 109)

0.896

 Fluid balance, mL

570 (10, 1200)

500 (− 50, 1100)

 < 0.001

570 (0, 1200)

500 (0, 1100)

0.076

 Type of cardioplegia

  

 < 0.001

  

0.708

 Blood cardioplegia

1239 (65.5)

9099 (72.7)

 

1208 (64.3)

1219 (64.8)

 

 No cardioplegia

682 (25.5)

3423 (27.3)

 

672 (35.7)

661 (35.2)

 
  1. Abbreviations: ACC aortic cross-clamp, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, AST aspartate aminotransferase, ALT alanine aminotransferase, BMI body mass index; BSA, body surface area, CABG coronary artery bypass grafting, CCB calcium channel blocker, CPB cardiopulmonary bypass, EF ejection fraction, HCT hematocrit, HES hydroxyethyl starch, PSM propensity score matching